Literature DB >> 3580708

The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.

R Corder, P J Lowry, P G Withrington.   

Abstract

The two peptides, neuropeptide Y (NPY) and peptide YY (PYY) were compared for potency on the vascular and extravascular smooth muscle of the isolated, blood-perfused spleen of the dog. The only vascular response to both NPY and PYY was vasoconstriction; the maximum effect was to arrest splenic arterial blood flow completely. On a molar basis both NPY and PYY were significantly more potent (P less than 0.01) as splenic arterial vasoconstrictors than the transmitter noradrenaline (NA). PYY was approximately 7 times more potent as a vasoconstrictor than NPY. In contrast to their potency on the vascular smooth muscle, NPY and PYY were significantly (P less than 0.01) less potent than NA in causing contraction of the splenic capsule. The two peptides were equipotent in eliciting this contraction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580708      PMCID: PMC1917199          DOI: 10.1111/j.1476-5381.1987.tb11232.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  The responses of the isolated, blood-perfused spleen of the dog to angiotensin, oxytocin and vasopressin.

Authors:  B N Davies; P G Withrington
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control.

Authors:  J M Lundberg; A Anggård; J Pernow; T Hökfelt
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

3.  The effects of graded doses of phenoxybenzamine on the vascular and capsular responses of the isolated, blood-perfused dogs spleen to sympathetic nerve stimulation and catecholamines.

Authors:  B N Davies; B H Robinson; P G Withrington
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-07

4.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.

Authors:  J M Lundberg; K Tatemoto
Journal:  Acta Physiol Scand       Date:  1982-12

5.  Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig.

Authors:  R Uddman; E Ekblad; L Edvinsson; R Håkanson; F Sundler
Journal:  Regul Pept       Date:  1985-03

6.  Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility.

Authors:  J M Lundberg; K Tatemoto; L Terenius; P M Hellström; V Mutt; T Hökfelt; B Hamberger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Neuropeptide Y: complete amino acid sequence of the brain peptide.

Authors:  K Tatemoto
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Erythrocyte uptake by the dog's spleen during splenic venous pressure elevation.

Authors:  P G Withrington; P D Richardson; B N Davies
Journal:  Pflugers Arch       Date:  1980-10       Impact factor: 3.657

9.  Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation.

Authors:  J M Lundberg; A Anggård; E Theodorsson-Norheim; J Pernow
Journal:  Neurosci Lett       Date:  1984-11-23       Impact factor: 3.046

10.  Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels.

Authors:  L Edvinsson; E Ekblad; R Håkanson; C Wahlestedt
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

View more
  8 in total

1.  PYY-like material and its spatial relationship with NPY, CGRP and 5-HT in the lung of the Syrian golden hamster.

Authors:  I M Keith; R Ekman
Journal:  Cell Tissue Res       Date:  1990-12       Impact factor: 5.249

2.  The relaxant properties of human calcitonin gene-related peptide on vascular and extravascular capsular) smooth muscle of the isolated blood-perfused spleen of the anaesthetized dog.

Authors:  P G Withrington
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

3.  A comparison of the differential effects of vasoactive intestinal peptide and peptide histidine isoleucine on the vascular and capsular smooth muscle of the dog spleen.

Authors:  R Corder; P G Withrington
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

4.  The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog.

Authors:  P G Withrington; N Ansari; R Croxton; G de Nucci; J R Vane
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

5.  Inhibitory effects of neuropeptide Y on sympathetic neurotransmission in the rabbit iris-ciliary body.

Authors:  S E Ohia; J E Jumblatt
Journal:  Neurochem Res       Date:  1990-03       Impact factor: 3.996

6.  Modulation by endogenous prostanoids of the vasoconstrictor activity of endothelin-1 in the canine isolated, perfused spleen.

Authors:  D M Grassi-Kassisse; E Antunes; P G Withrington; G de Nucci
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

7.  Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo.

Authors:  R O Salonen; S E Webber; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

8.  The actions of neuropeptide Y and peptide YY on the hepatic arterial and portal vascular beds of the anaesthetized dog.

Authors:  R Corder; P G Withrington
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.